Swiss Biotech Day 2025

Event Date:
5–6 May 2025
Location:
Congress Center Basel, Switzerland

Richmond Pharmacology is pleased to confirm our participation at Swiss Biotech Day 2025

View Event

CRISPR Medicine 2025: Unlocking Gene-Editing Potential

Event Date:
April 7–11
Location:
Basel, Switzerland

Exploring advancements shaping the future of healthcare.

View Event

ESC Preventive Cardiology 2025: Proactive Healthcare Strategies

Event Date:
April 3–5
Location:
Lisbon, Portugal.

Innovating practices to prevent cardiovascular diseases.

View Event

ACC 2025: Breaking Barriers in Cardiovascular Research

Event Date:
March 29–31
Location:
Chicago, USA

Advancing cardiology through research and collaboration.

View Event

Healthcare Innovation Event 2025: Pioneering the Future

Event Date:
March 26
Location:
Boston, USA

Engage with thought leaders shaping medical research.

View Event

DIA Europe 2025: Collaboration and Innovation in Healthcare

Event Date:
March 18–20
Location:
Basel, Switzerland

Uniting global leaders to reshape healthcare’s future.

View Event

ESC Acute Cardiovascular Care 2025: Revolutionizing Cardiology

Event Date:
March 14–15
Location:
Athens, Greece

Insights and breakthroughs for acute cardiovascular treatments.

View Event

British Science Week: Advancing Science and Research

Event Date:
March 7–16
Location:
UK (Various)

Celebrating the innovations shaping everyday life.

View Event

ACDM25: Shaping the Future of Clinical Data Management

Event Date:
March 2–4
Location:
Prague, Czechia

Explore advancements in managing and leveraging clinical data.

View Event

Patient Centricity & Collaboration World Congress

Event Date:
February 25–26
Location:
London, UK

Discover innovative strategies for putting patients at the heart of healthcare.

View Event

Latest news

Richmond Appoints Lisa Campbell as Director of Regulatory Strategy

April 23, 2025
Richmond Pharmacology is pleased to announce the appointment of Lisa Campbell as Director of Regulatory Strategy
Read more

Von Willebrand Disease Trial – First Stage of Hemab Therapeutics’ Trial Completed and New Patients Invited to Enrol

April 2, 2025
Richmond has completed dosing the first cohort of patients in Velora Pioneer, a phase 1/2 clinical trial investigating Hemab...
Read more

Events

Swiss Biotech Day 2025

5–6 May 2025
Richmond Pharmacology is pleased to confirm our participation at Swiss Biotech Day 2025
View event